Our archives contain a rich repository of research articles published in previous issues of the Journal of Research in Pharmaceutics. These archives serve as a valuable resource for researchers, practitioners, and students in the pharmaceutical sciences.
Explore Past Issues
Volume 2
Issue 1 JANUARY- JUNE 2025
Volume 2(Issue 1) JANUARY- JUNE 2025 Research Articles
Including Humanistic and Narrative Methods in Contemporary Pharmacy Practice
Vol.2(1); Pages:1-8. Published on April 2025
Abstract
Pharmaceutical Humanities along with Narrative Pharmacy establish an expanding interdisciplinary method that brings humanistic approaches and ethical and narrative practices to pharmaceutical practice. The focus of this concept underscores the importance of patient stories together with empathy along with cultural awareness in medication therapy management to improve patient-centered care. Through its interdisciplinary approach Narrative Pharmacy creates stronger relationships with patients and enhances healthcare communication and makes healthcare decisions more ethical for pharmaceutical care delivery. The developing field demonstrates why storytelling techniques together with ethical considerations and social science methods need to form the basis of complete pharmaceutical educational approaches and clinical practice methods.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Strengthening the Competitiveness and Adaptability of Serbian Pharmacies in the Digital Era
Vol.2(1); Pages:9-15. Published on April 2025
Abstract
Pharmaceutical Humanities along with Narrative Pharmacy establish an expanding interdisciplinary method that brings humanistic approaches and ethical and narrative practices to pharmaceutical practice. The focus of this concept underscores the importance of patient stories together with empathy along with cultural awareness in medication therapy management to improve patient-centered care. Through its interdisciplinary approach Narrative Pharmacy creates stronger relationships with patients and enhances healthcare communication and makes healthcare decisions more ethical for pharmaceutical care delivery. The developing field demonstrates why storytelling techniques together with ethical considerations and social science methods need to form the basis of complete pharmaceutical educational approaches and clinical practice methods.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Blended Learning in Pharmacy Administration and Regulation: Merging Online and Offline Education for Better Outcomes
Vol.2(1); Pages:16-23. Published on April 2025
Abstract
Educational models which combine virtual learning with classroom instruction named blended teaching have become widely adopted in Pharmacy Administration and Regulation education. This instructional framework unites conventional classroom discussions with digital educational resources alongside interactive interfaces and autonomous study methods to better students’ participation rates and educational success rates and competence development. The integration of blended teaching with pharmacy administration classes resolves classroom pedagogical issues which include minimal student-student contact and passive learning methods along with variable student learning speeds. This paper examines blended teaching applications in pharmacy regulation and administration while showing how the approach enhances concept mastery and regulatory standards instruction and decision-making competencies. Interactive learning environments form through the utilization of technological tools including learning management systems and virtual simulations and case studies and discussion forums and real-world regulatory scenarios within blended teaching programs. The study evaluates different blended teaching methods like flipped classrooms combined with hybrid learning and problem-based learning (PBL) and reviews their effectiveness on student achievement and professional competency. Data collected from empirical research demonstrates that blended educational approaches strengthen students’ interpretive abilities and analytical reasoning and critical thinking capabilities for pharmaceutical policies and rules. Through blended learning students can manage their professional training with their academic coursework due to its flexible format. The article examines technological restrictions as well as student adoption struggles and faculty system preparation requirements which identifies successful implementation methods. The research demonstrates that pharmacy education requires faculty training while simultaneously requiring curriculum reorganizing and regular outcome assessment systems to achieve ideal blended teaching success.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Scientometric-Based Technology Foresight Index for Informed Pharmacology and Pharmacy Policy-Making
Vol.2(1); Pages:24-32. Published on April 2025
Abstract
The process of technology foresight acts as a fundamental tool for producing policies within science and technology (S&T) domains especially within the dynamic arenas of pharmacology and pharmacy. The study creates a Technology Foresight Index (TFI) as a policy-making support instrument which utilizes scientometric methods to evaluate upcoming patterns and analyze research potential and scholarly effects. A thorough analysis of pharmaceutical progress factors emerges from bibliometric database research that investigates international research frequency and citations together with networking activities and funding allocations. Research mapping of pharmacology’s evolution uses scientometric indicators which analyze publication growth with citation influence and keyword co-occurrence in addition to research clustering methods. Through the implementation of machine learning we establish future-oriented predictions concerning research paths and technological advancements. Pharmaceutical innovation receives shape from three main elements which include patents alongside regulatory frameworks and intersectoral cooperative efforts. Through the TFI framework researchers obtain quantitative research data which enables policy officials to base their pharmaceutical policy decisions on factual evidence for global success. The results demonstrate why data-based foresight approaches are essential for organizations to maximize their resource deployment and stimulate innovation efforts which makes the pharmaceutical industry both enduring and competitive.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Efficacy of Community Pharmacy Based Take-Home Naloxone Programs in Overdose Prevention
Vol.2(1); Pages:33-40. Published on April 2025
Abstract
Community pharmacies now run important take-home naloxone programs that aim to decrease opioid overdose deaths as a main public health approach. Pharmacists implement THN programs which allow them to give out naloxone prescriptions-free to persons who face opioid overdose risk along with their support networks. The study investigates multiple research works which explore THN program implementation aspects as well as obstacles and outcomes for pharmacy environments. Reports indicate the main obstacles lie in pharma community resistance to naloxone administration because of social disapproval and insufficient staff preparation and restrictive legal requirements together with inconsistent patient learning programs. When combined programs include pharmacist education and standing orders together with targeted counseling and harm reduction training they enhance both naloxone dispensing rates and public awareness. Research shows that active pharmacy-based harm reduction programs help community pharmacies succeed in reducing opioid-related deaths and increasing naloxone distribution numbers. Research studies emphasize that communitywide public health initiatives together with strategic policy changes create expanded benefits from these health programs. Future studies must explore how well patients continue with treatment and how pharmacists engage with naloxone distribution and what longer-term effects of these programs will be. Research emphasizes the necessity to combine various strategies which enable improvement of THN program outcomes within community pharmacy environments.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Volume 1
Issue 2 JULY – DECEMBER 2024
Research Articles Volume 1 (Issue 2) JULY – DECEMBER 2024
Pharmacy Ethics and Professionalism Case Studies and Best Practices
Vol.1(2); Pages:1-7. Published on July 2024
Abstract
Pharmacy operations are fundamental to healthcare delivery, ensuring the accurate and timely dispensing of medications. However, inefficiencies and errors in pharmacy workflows can compromise patient safety and service quality. This study aims to evaluate the impact of workflow optimization on patient safety and service quality within pharmacy settings. By examining various methods for optimizing workflows, such as Lean Six Sigma, automation, and process reengineering, the study assesses their effectiveness in improving operational performance and patient outcomes. A comprehensive literature review was conducted, focusing on peer-reviewed articles and studies published in the last decade. Databases such as PubMed, Google Scholar, IE eXplore, and Scopus were searched using keywords including “pharmacy workflow optimization,” “process improvement,” “medication dispensing efficiency,” and “pharmacy automation.” Studies that met the inclusion criteria were analysed to identify common themes and outcomes related to workflow optimization in pharmacy settings. The review identified several key methods for workflow optimization, including Lean Six Sigma, automation, and process reengineering. Studies consistently demonstrated that these methods lead to significant improvements in efficiency, reducing wait times for patients and increasing the accuracy of medication dispensing. Moreover, optimized workflows were associated with a substantial reduction in medication errors, enhancing patient safety. Staff satisfaction also improved due to better workload distribution and reduced stress levels.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Multivariate Analysis of Pharma Technology Transfer: Addressing Civilization Diseases and COVID-19 Challenges
Vol.1(2); Pages:8-17. Published on August 2024
Abstract
Pharmaceutical technology transfer has emerged as a critical process in enabling global access to innovative therapies, particularly in light of escalating civilization diseases and the COVID-19 pandemic. This paper presents a comprehensive multivariate analysis of pharma technology transfer, focusing on how this mechanism can address both longstanding civilization diseases such as cardiovascular conditions, diabetes, and cancer—and the acute, worldwide healthcare crisis caused by COVID-19. The transfer of pharmaceutical technologies encompasses the complex movement of know-how, manufacturing capabilities, and intellectual property between organizations, countries, and sectors. The study analyzes the diverse factors influencing the efficacy of technology transfer, including regulatory frameworks, intellectual property rights, cost structures, and collaborative partnerships. Using a multivariate approach, the research examines correlations between technology transfer success rates and key variables such as the availability of funding, regulatory compliance, infrastructure readiness, and human resource capabilities. In the context of civilization diseases, the analysis highlights the role of technology transfer in scaling up production of critical medications, advancing precision medicine, and improving global health equity. The study further investigates how the COVID-19 pandemic accelerated pharma technology transfer initiatives through rapid collaboration across international borders and public-private partnerships, which spurred the development, manufacturing, and distribution of vaccines and therapies.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Assessment of Knowledge and Perceptions Regarding Pharmacovigilance Activities among Pharmacy Students in Nigeria: A Cross-Sectional Study
Vol.1(2); Pages:18-26. Published on September 2024
Abstract
This cross-sectional study aimed to assess the knowledge and perceptions about pharmacovigilance activities among pharmacy students in Nigeria. A structured questionnaire was administered to 400 pharmacy students from various institutions. The study explored their understanding of pharmacovigilance, the importance of adverse drug reaction reporting, and the factors influencing their knowledge and perceptions. Results indicated a moderate level of knowledge about pharmacovigilance among the students, with many recognizing its importance but lacking detailed understanding. The study highlights the need for targeted educational interventions to improve pharmacovigilance knowledge among pharmacy students in Nigeria.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Credentialing and Privileging of Pharmacists A Resource Paper from the Council on Credentialing in Pharmacy
Vol.1(2); Pages:27-35. Published on October-2024
Abstract
This resource paper from the Council on Credentialing in Pharmacy provides a comprehensive overview of the credentialing and privileging processes for pharmacists. It emphasizes the importance of these processes in ensuring the competence and accountability of pharmacists in various practice settings. The paper discusses the role of credentialing in verifying qualifications, education, training, and practice history, while privileging determines the scope of practice and responsibilities. It highlights the need for standardized and consistent approaches to credentialing and privileging to support safe, effective, and high-quality pharmacy practice.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Evaluating Patient Satisfaction with Pharmacy Services in Tertiary Care Hospitals: A Comprehensive Review
Vol.1(2); Pages:36-44. Published on October-2024
Abstract
Patient satisfaction is a critical metric for assessing the quality and effectiveness of healthcare services, including pharmacy services in tertiary care hospitals. This review explores the determinants, methodologies, and outcomes associated with patient satisfaction in pharmacy services. Key factors such as accessibility, counseling quality, medication availability, waiting times, and pharmacist-patient interactions are analyzed. The review also highlights regional and institutional variations in satisfaction levels and the role of modern technologies, such as e-pharmacy and automated dispensing systems, in enhancing service quality. Addressing gaps in patient expectations and service delivery, the study underscores strategies for continuous improvement in pharmacy services to achieve optimal patient satisfaction and better healthcare outcomes.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Issue 1 JANUARY – JUNE 2024
Research Articles Volume 1 (Issue 1) JANUARY – JUNE 2024
Artificial Intelligence (AI) in Pharmacy: An Overview of Innovations
Vol.1(1); Pages:1-6. Published on May 2024
Abstract
Artificial Intelligence (AI) is transforming various industries, and pharmacy is no exception. This paper provides an overview of the significant innovations AI has introduced to pharmacy practice. By leveraging machine learning algorithms and natural language processing, AI enhances drug discovery, personalizes medication therapy, and optimizes supply chain management. The integration of AI in pharmacy has led to improved patient outcomes through predictive analytics, more accurate dosage calculations, and reduced medication errors. This overview highlights current applications, potential challenges, and future directions for AI in pharmacy, underscoring its pivotal role in modern healthcare. The integration of Artificial Intelligence (AI) into the pharmacy sector is revolutionizing the way medications are developed, dispensed, and managed, leading to enhanced patient care and operational efficiency. This paper provides a comprehensive overview of the innovative applications of AI in pharmacy, focusing on key areas such as drug discovery, personalized medicine, medication management, and pharmacy operations. By leveraging machine learning algorithms and data analytics, AI is enabling researchers to identify potential drug candidates more rapidly and accurately, significantly reducing the time and cost associated with traditional drug development processes. In clinical settings, AI-driven tools are improving medication adherence and optimizing therapeutic outcomes through personalized treatment plans tailored to individual patient profiles. Furthermore, AI technologies are streamlining pharmacy operations by automating inventory management, predicting medication demand, and enhancing the accuracy of prescription processing. This overview highlights the transformative potential of AI in pharmacy, while also addressing the challenges and ethical considerations associated with its implementation. By examining current innovations and future directions, this paper aims to provide insights into how AI can continue to shape the future of pharmacy practice and improve healthcare delivery.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Optimizing Pharmacy Operations through Performance Metrics and KPIs
Vol.1(1); Pages:7-14. Published on May 2024
Abstract
In the dynamic and increasingly complex field of pharmacy, achieving operational efficiency and delivering highquality patient care are paramount. “Enhancing Pharmacy Efficiency: Key Performance Metrics and KPIs for Optimal Operations” explores the pivotal role of performance metrics and Key Performance Indicators (KPIs) in optimizing pharmacy operations. This paper examines how strategically selected KPIs such as prescription fill time, medication error rate, inventory turnover, and patient satisfaction scores can provide valuable insights into the effectiveness and efficiency of pharmacy practices. By integrating advanced data analytics and real-time monitoring tools, pharmacies can gain a comprehensive view of their performance, identify areas for improvement, and implement targeted strategies to enhance operational outcomes. The study also highlights the impact of these metrics on the paper demonstrates how a focus on key performance metrics can drive continuous improvement, streamline operations, and ultimately lead to better patient outcomes. The findings underscore the transformative potential of leveraging performance metrics and KPIs to foster a culture of excellence and achieve optimal efficiency in pharmacy operations.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmacokinetic drug-drug interaction and their implication in clinical management
Vol.1(1); Pages:15-24. Published on June 2024
Abstract
Pharmacokinetic drug-drug interactions (DDIs) are significant considerations in clinical management, influencing drug efficacy and safety. These interactions occur when one drug alters the absorption, distribution, metabolism, or excretion of another, leading to changes in drug plasma concentrations and therapeutic outcomes. Understanding the mechanisms underlying pharmacokinetic DDIs is crucial for healthcare providers to prevent adverse effects and optimize therapeutic regimens. This abstract explores the primary mechanisms of pharmacokinetic interactions, including enzyme induction and inhibition, transporter modulation, and alterations in drug bioavailability. It also discusses the clinical implications of these interactions, emphasizing the importance of personalized medicine, therapeutic drug monitoring, and patient education in managing DDIs. The integration of advanced technologies and pharmacogenomics into clinical practice offers promising strategies for predicting and mitigating pharmacokinetic DDIs, ultimately enhancing patient safety and treatment efficacy. Pharmacokinetic drug-drug interactions (DDIs) pose a considerable challenge in clinical practice, as they can significantly affect the pharmacological profile of medications, leading to altered therapeutic outcomes and potential adverse effects. These interactions primarily occur through modifications in the processes of absorption, distribution, metabolism, and excretion (ADME) of drugs. For instance, enzyme induction or inhibition can profoundly impact drug metabolism, leading to either subtherapeutic levels or toxic concentrations of the affected drug. Similarly, the modulation of drug transporters can influence drug distribution and excretion, altering plasma drug levels. Clinical management of pharmacokinetic DDIs necessitates a thorough understanding of these mechanisms to tailor treatment regimens appropriately. Healthcare providers must employ strategies such as therapeutic drug monitoring, patient-specific dosing adjustments, and comprehensive patient education to mitigate the risks associated with DDIs. The advent of pharmacogenomics and advanced diagnostic technologies holds promise in predicting individual susceptibility to DDIs, enabling more personalized and safer therapeutic interventions. By integrating these approaches, clinicians can better navigate the complexities of pharmacokinetic DDIs, ensuring optimal therapeutic efficacy and patient safety.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmacy automation and robotics in healthcare
Vol.1(1); Pages:25-31. Published on June 2024
Abstract
Pharmacy automation and robotics are transforming healthcare by streamlining pharmaceutical operations, enhancing accuracy, and improving patient outcomes. Automated systems and robotic technologies are increasingly being utilized in various pharmacy functions, from medication dispensing and compounding to inventory management and order verification. These advancements reduce the risk of human error, increase efficiency, and allow pharmacists to devote more time to direct patient care. The integration of automation and robotics in pharmacy practice also supports adherence to stringent regulatory standards and enhances workflow efficiency. This abstract explores the current state of pharmacy automation and robotics, their implications for healthcare delivery, and future directions in this rapidly evolving field.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Research and Development in the Pharmaceutical Industry
Vol.1(1); Pages:32-41. Published on June 2024
Abstract
Pharmacokinetic drug-drug interactions (DDIs) are significant considerations in clinical management, influencing drug efficacy and safety. These interactions occur when one drug alters the absorption, distribution, metabolism, or excretion of another, leading to changes in drug plasma concentrations and therapeutic outcomes. Understanding the mechanisms underlying pharmacokinetic DDIs is crucial for healthcare providers to prevent adverse effects and optimize therapeutic regimens. This abstract explores the primary mechanisms of pharmacokinetic interactions, including enzyme induction and inhibition, transporter modulation, and alterations in drug bioavailability. It also discusses the clinical implications of these interactions, emphasizing the importance of personalized medicine, therapeutic drug monitoring, and patient education in managing DDIs. The integration of advanced technologies and pharmacogenomics into clinical practice offers promising strategies for predicting and mitigating pharmacokinetic DDIs, ultimately enhancing patient safety and treatment efficacy. Pharmacokinetic drug-drug interactions (DDIs) pose a considerable challenge in clinical practice, as they can significantly affect the pharmacological profile of medications, leading to altered therapeutic outcomes and potential adverse effects. These interactions primarily occur through modifications in the processes of absorption, distribution, metabolism, and excretion (ADME) of drugs. For instance, enzyme induction or inhibition can profoundly impact drug metabolism, leading to either subtherapeutic levels or toxic concentrations of the affected drug. Similarly, the modulation of drug transporters can influence drug distribution and excretion, altering plasma drug levels. Clinical management of pharmacokinetic DDIs necessitates a thorough understanding of these mechanisms to tailor treatment regimens appropriately. Healthcare providers must employ strategies such as therapeutic drug monitoring, patient-specific dosing adjustments, and comprehensive patient education to mitigate the risks associated with DDIs. The advent of pharmacogenomics and advanced diagnostic technologies holds promise in predicting individual susceptibility to DDIs, enabling more personalized and safer therapeutic interventions. By integrating these approaches, clinicians can better navigate the complexities of pharmacokinetic DDIs, ensuring optimal therapeutic efficacy and patient safety.
View Full PDF
Please LOGIN to View Full PDF or Read more.
All articles in the archive are available for download in PDF format. If you encounter any issues or need assistance accessing older volumes, please contact us.
